In type 2 diabetes trials (the SUSTAIN program), Ozempic produced an average weight loss of around 4.5 kg to 6.5 kg (roughly 10 to 14 lbs) over 52 weeks, depending on the dose
To evaluate the convergence of published results, we first conduct a multi-level kernel density meta-analysis of studies reporting a positive association of ghrelin ( N comb = 353, 18 contrasts) and a negative association of GLP-1 ( N comb = 258, 12 contrasts) and reward responses measured using task functional magnetic resonance imaging (fMRI)
Regarding cost, Semaglutide in Fullerton, CA typically ranges from $600 to $1,500 per month, depending on the specific formulation
And it's not what most people expect
semaglutide consistently demonstrated superior glycemic control and weight loss versus either other anti-hyperglycemic agents or other GLP-1 RAs, in a variety of T2D patient cohorts [reviewed in (11)]